GOST R 52249-2009 PDF

Full title and description

GOST R 52249-2009 — "Правила производства и контроля качества лекарственных средств" (Good Manufacturing Practice for medicinal products, GMP). The standard sets national Russian requirements for the organization, production, quality control and release of medicinal products and active pharmaceutical substances; it is largely aligned with the EU Guide to Good Manufacturing Practice as of January 31, 2009.

Abstract

GOST R 52249-2009 defines requirements for a pharmaceutical quality system, personnel, premises and equipment, documentation, production, in‑process and laboratory quality control, contract working, complaints and recalls, and self‑inspection. The document is published in two parts (general requirements and requirements for active pharmaceutical substances) and includes numerous annexes addressing specific product types and technologies (sterile products, biologicals, radiopharmaceuticals, APIs, computerized systems, etc.).

General information

• Status: National standard in force (GOST R).
• Publication date: Approved 20 May 2009 (Order No. 159‑ст); date of entry into force 1 January 2010.
• Publisher: Approved by the Federal Agency for Technical Regulation and Metrology (Rosstandart); commonly published/distributed by national standards publishers (e.g., Standartinform / standards distributors).
• ICS / categories: Healthcare / Pharmaceuticals — classification mapped to health technology and pharmaceuticals (approx. ICS 11.120 / pharmaceuticals).
• Edition / version: 2009 edition (GOST R 52249‑2009). Effective 1 Jan 2010.
• Number of pages: Approximately 138–139 pages (varies by publisher/format).

Scope

The standard applies to the manufacture and quality control of medicinal products for human and veterinary use and to active pharmaceutical substances (APIs). It covers all stages from receipt of raw materials, manufacture, packaging and labeling, to storage, distribution and release, including special provisions and annexes for sterile products, biologicals, radiopharmaceuticals, clinical trial materials, medical gases and other specific processes. The standard is intended for organizations that develop, manufacture, control or contract‑manufacture medicinal products or APIs in the territory where GOST R requirements apply.

Key topics and requirements

• Quality management system and responsibilities of the authorized (qualified) person.
• Personnel qualification, hygiene and training requirements.
• Premises, cleanrooms and controlled environments (air handling, zones, material/ personnel flows).
• Equipment qualification, maintenance and calibration.
• Documentation, record keeping, and change control (SOPs, batch records, validation protocols).
• Production controls, in‑process checks and contamination prevention.
• Quality control laboratory testing, sampling, stability testing and retention samples.
• Requirements for contract manufacturing and analytical testing.
• Complaints handling, product recall procedures and self‑inspection (internal audits).
• Specific annexes covering sterile manufacturing, biologicals, radiopharmaceuticals, APIs, computerized systems and other specialized processes.

Typical use and users

Used by pharmaceutical manufacturers, API producers, contract manufacturing organizations (CMOs), quality assurance/quality control personnel, regulatory affairs specialists and auditors in Russia and organizations exporting to or operating within the Russian regulatory environment. It is also referenced by consultants, certification bodies and national laboratories when assessing GMP compliance.

Related standards

Related/ referenced documents include the EU Guide to Good Manufacturing Practice (the text to which GOST R 52249‑2009 is largely aligned), ISO / GOST standards on cleanrooms and controlled environments (e.g., GOST R ISO 14644 series equivalents), and earlier national version GOST R 52249‑2004 which this standard replaced. Regional EAEU (Eurasian) GMP rules and subsequent regulatory documents also interact with national GMP requirements.

Keywords

GOST R 52249‑2009; GMP; Good Manufacturing Practice; pharmaceutical quality; quality control; active pharmaceutical substances; sterile production; cleanrooms; Rosstandart; Russia.

FAQ

Q: What is this standard?

A: GOST R 52249‑2009 is the Russian national Good Manufacturing Practice standard titled "Правила производства и контроля качества лекарственных средств" — it establishes GMP requirements for manufacture and quality control of medicinal products and APIs.

Q: What does it cover?

A: It covers the full pharmaceutical manufacturing and quality system: organization and QA, personnel, premises/equipment, production and process controls, analytical testing and release, documentation, validation, contract work, complaints and recalls, and multiple technical annexes for specific product types and technologies.

Q: Who typically uses it?

A: Pharmaceutical and API manufacturers, CMOs, QA/QC staff, regulatory affairs professionals, certification bodies and auditors working in or with the Russian market.

Q: Is it current or superseded?

A: GOST R 52249‑2009 is the 2009 national GMP standard and remains a referenced national document. At the same time, regional EAEU (Eurasian) GMP rules and ongoing regulatory developments (introduced after 2009 and notably referenced from 2013–2016 onward) affect regional practice and may be applied in parallel; organizations should check the latest national and EAEU regulatory instruments and Rosstandart notices for any amendments or supersessions before relying on a single source.

Q: Is it part of a series?

A: Yes — the standard has two main parts (general requirements and requirements for APIs) and numerous annexes addressing product‑ and process‑specific GMP topics; it supersedes the earlier GOST R 52249‑2004 edition.

Q: What are the key keywords?

A: GMP, Good Manufacturing Practice, pharmaceutical quality, quality control, API, sterile production, cleanrooms, Rosstandart, GOST R 52249‑2009.